Evidence map›Paper›PMID 42353002›Full record

ReviewInternational journal of molecular sciences2026

Kiran Reddy Kanubaddi, Chih-Liang Yaung, Horng-Jyh Harn, Tzyy-Wen Chiou, Shao-Xi Hsu, Ivan Wijaya, Shinn-Zong Lin, Wei Wuli

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kiran Reddy KanubaddiDepartment of Physics, National Dong Hwa University, Hualien 97401, Taiwan.
Chih-Liang YaungDepartment of Healthcare Administration, Asia University, Taichung 413305, Taiwan.
Horng-Jyh HarnDepartment of Pathology, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan.
Tzyy-Wen ChiouDepartment of Life Science, National Dong Hwa University, Hualien 974301, Taiwan.
Shao-Xi HsuDepartment of Life Science, National Dong Hwa University, Hualien 974301, Taiwan.
Ivan WijayaBioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan.
Shinn-Zong LinDepartment of Neurology, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan.
Wei WuliBioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is associated with a rising burden of chronic metabolic, cardiovascular, musculoskeletal, and neurodegenerative diseases that share interconnected pathological mechanisms, including oxidative stress, chronic inflammation, mitochondrial dysfunction, metabolic imbalance, and immune dysregulation. Because these disorders arise from complex and overlapping biological disturbances, conventional single-target therapies often provide only limited benefit. In this context, traditional Chinese herbal medicines, characterized by multi-component and multi-target actions, are being re-evaluated using modern pharmacological and systems biology approaches. Among these,

Indexed as

AgingAstragalus PlantCordycepsDrugs, Chinese HerbalNeurodegenerative DiseasesAnimalsChronic DiseaseHumansDrugs, Chinese HerbalagingAstragalus membranaceusCordycepsmulti-target therapytraditional Chinese herbal medicine

Identifiers

PMID42353002
PMCPMC13299804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.